Glucocorticoid receptor β regulates injury-mediated astrocyte activation and contributes to glioma pathogenesis via modulation of β-catenin/TCF transcriptional activity

Neurobiology of Disease

Volumn 59, Issue , 2013, Pages 165-176

  Yin, Ying ^a,b   Zhang, Xiufen ^a,b,c   Li, Zaiwang ^a,b   Deng, Lingxiao ^a,d   Jiao, Guoqing ^b   Zhang, Bin ^a,b   Xie, Ping ^a,b   Mu, Huijun ^a,b   Qiao, Weizhen ^a,b   Zou, Jian ^a,b  

^a WUXI PEOPLE S HOSPITAL AFFILIATED TO NANJING MEDICAL UNIVERSITY   (China)

^b Wuxi Clinical Science Research Institute   (China)

^c SOOCHOW UNIVERSITY   (China)

^d INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Catenin; Astrocyte activation; Glioma malignancy; Glucocorticoid receptor

Indexed keywords

BETA CATENIN; GLUCOCORTICOID RECEPTOR ALPHA; GLUCOCORTICOID RECEPTOR BETA; SMALL INTERFERING RNA; T CELL FACTOR PROTEIN;

ANIMAL CELL; ARTICLE; ASTROCYTOMA; CELL ACTIVATION; CELL MIGRATION; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; EMBRYO; GENE; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GENE SILENCING; GLIOMA; GLIOMA CELL; GRBETA GENE; HUMAN; HUMAN CELL; IN VITRO STUDY; INTRACELLULAR SIGNALING; MEDULLOBLASTOMA; NERVE CELL LESION; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; TRANSCRIPTION REGULATION;

ASTROCYTE ACTIVATION; GLIOMA MALIGNANCY; GLUCOCORTICOID RECEPTOR Β; Β-CATENIN;

ASTROCYTES; BETA CATENIN; BRAIN NEOPLASMS; CELL CYCLE; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOMA; GLUCOCORTICOIDS; GREEN FLUORESCENT PROTEINS; HUMANS; NEOPLASM INVASIVENESS; NERVE TISSUE PROTEINS; RECEPTORS, GLUCOCORTICOID; SIGNAL TRANSDUCTION; TCF TRANSCRIPTION FACTORS; TRANSCRIPTIONAL ACTIVATION;

EID: 84882935846     PISSN: 09699961     EISSN: 1095953X     Source Type: Journal    
DOI: 10.1016/j.nbd.2013.07.013     Document Type: Article

References (55)

1. Bamberger C.M., et al. Glucocorticoid receptor beta, a potential endogenous inhibitor of glucocorticoid action in humans. J. Clin. Invest. 1995, 95:2435-2441.
2. Bavaresco L., et al. Dexamethasone inhibits proliferation and stimulates ecto-5'-nucleotidase/CD73 activity in C6 rat glioma cell line. J. Neurooncol. 2007, 84:1-8.
3. Chen L., et al. beta-catenin/Tcf-4 complex transcriptionally regulates AKT1 in glioma. Int. J. Oncol. 2011, 39:883-890.
4. Etienne-Manneville S., Hall A. Cdc42 regulates GSK-3beta and adenomatous polyposis coli to control cell polarity. Nature 2003, 421:753-756.
5. Galliher-Beckley A.J., et al. Glycogen synthase kinase 3beta-mediated serine phosphorylation of the human glucocorticoid receptor redirects gene expression profiles. Mol. Cell. Biol. 2008, 28:7309-7322.
6. Gilbert C.A., Ross A.H. Cancer stem cells: cell culture, markers, and targets for new therapies. J. Cell. Biochem. 2009, 108:1031-1038.
7. Goleva E., et al. Increased glucocorticoid receptor beta alters steroid response in glucocorticoid-insensitive asthma. Am. J. Respir. Crit. Care Med. 2006, 173:607-616.
8. Gross K.L., et al. Glucocorticoid receptor alpha isoform-selective regulation of antiapoptotic genes in osteosarcoma cells: a new mechanism for glucocorticoid resistance. Mol. Endocrinol. 2011, 25:1087-1099.
9. Han L., et al. Inactivation of PI3K/AKT signaling inhibits glioma cell growth through modulation of beta-catenin-mediated transcription. Brain Res. 2010, 1366:9-17.
10. Harwood A.J. Regulation of GSK-3: a cellular multiprocessor. Cell 2001, 105:821-824.
11. He X., et al. Glycogen synthase kinase-3 and dorsoventral patterning in Xenopus embryos. Nature 1995, 374:617-622.
12. Ismaili N., Garabedian M.J. Modulation of glucocorticoid receptor function via phosphorylation. Ann. N. Y. Acad. Sci. 2004, 1024:86-101.
13. Jang H.D., et al. Inactivation of glycogen synthase kinase-3beta is required for osteoclast differentiation. J. Biol. Chem. 2011, 286:39043-39050.
14. Katiyar P., Aplin A.E. FOXD3 regulates migration properties and Rnd3 expression in melanoma cells. Mol. Cancer Res. 2011, 9:545-552.
15. Kaur N., et al. Wnt3a mediated activation of Wnt/beta-catenin signaling promotes tumor progression in glioblastoma. Mol. Cell. Neurosci. 2013, 54:44-57.
16. Kino T., et al. Human glucocorticoid receptor isoform beta: recent understanding of its potential implications in physiology and pathophysiology. Cell Mol. Life Sci. 2009, 66:3435-3448.
17. Korur S., et al. GSK3beta regulates differentiation and growth arrest in glioblastoma. PLoS One 2009, 4:e7443.
18. Lang B., et al. Astrocytes in injured adult rat spinal cord may acquire the potential of neural stem cells. Neuroscience 2004, 128:775-783.
19. Li Z., et al. Cyclin D1 regulates cellular migration through the inhibition of thrombospondin 1 and ROCK signaling. Mol. Cell. Biol. 2006, 26:4240-4256.
20. Liu J., et al. A small-molecule agonist of the Wnt signaling pathway. Angew. Chem. Int. Ed Engl. 2005, 44:1987-1990.
21. Liu W.L., et al. Methylprednisolone inhibits the expression of glial fibrillary acidic protein and chondroitin sulfate proteoglycans in reactivated astrocytes. Glia 2008, 56:1390-1400.
22. Liu H., et al. Dexamethasone inhibits proliferation and stimulates SSeCKS expression in C6 rat glioma cell line. Brain Res. 2009, 1265:1-12.
23. Maeda Y., et al. Polyamines modulate the interaction between nuclear receptors and vitamin D receptor-interacting protein 205. Mol. Endocrinol. 2002, 16:1502-1510.
24. Malaplate-Armand C., et al. Down-regulation of astroglial CYP2C, glucocorticoid receptor and constitutive androstane receptor genes in response to cocaine in human U373 MG astrocytoma cells. Toxicol. Lett. 2005, 159:203-211.
25. Moon R.T., et al. The promise and perils of Wnt signaling through beta-catenin. Science 2002, 296:1644-1646.
26. Mulholland D.J., et al. Interaction of nuclear receptors with the Wnt/beta-catenin/Tcf signaling axis: Wnt you like to know?. Endocr. Rev. 2005, 26:898-915.
27. Narasipura S.D., et al. Role of beta-catenin and TCF/LEF family members in transcriptional activity of HIV in astrocytes. J. Virol. 2011, 86:1911-1921.
28. Ni Chonghaile T., et al. Dexamethasone inhibits apoptosis in C6 glioma cells through increased expression of Bcl-XL. Apoptosis 2006, 11:1247-1255.
29. Nowicki M.O., et al. Lithium inhibits invasion of glioma cells; possible involvement of glycogen synthase kinase-3. Neuro. Oncol. 2008, 10:690-699.
30. Oakley R.H., Cidlowski J.A. Cellular processing of the glucocorticoid receptor gene and protein: new mechanisms for generating tissue-specific actions of glucocorticoids. J. Biol. Chem. 2011, 286:3177-3184.
31. Oakley R.H., et al. The human glucocorticoid receptor beta isoform. Expression, biochemical properties, and putative function. J. Biol. Chem. 1996, 271:9550-9559.
32. Oakley R.H., et al. The dominant negative activity of the human glucocorticoid receptor beta isoform. Specificity and mechanisms of action. J. Biol. Chem. 1999, 274:27857-27866.
33. Okada S., et al. Conditional ablation of Stat3 or Socs3 discloses a dual role for reactive astrocytes after spinal cord injury. Nat. Med. 2006, 12:829-834.
34. Olkku A., Mahonen A. Calreticulin mediated glucocorticoid receptor export is involved in beta-catenin translocation and Wnt signalling inhibition in human osteoblastic cells. Bone 2009, 44:555-565.
35. Pekny M., Nilsson M. Astrocyte activation and reactive gliosis. Glia 2005, 50:427-434.
36. Piette C., et al. The dexamethasone-induced inhibition of proliferation, migration, and invasion in glioma cell lines is antagonized by macrophage migration inhibitory factor (MIF) and can be enhanced by specific MIF inhibitors. J. Biol. Chem. 2009, 284:32483-32492.
37. Pu P., et al. Downregulation of Wnt2 and beta-catenin by siRNA suppresses malignant glioma cell growth. Cancer Gene Ther. 2009, 16:351-361.
38. Renault-Mihara F., et al. Beneficial compaction of spinal cord lesion by migrating astrocytes through glycogen synthase kinase-3 inhibition. EMBO Mol. Med. 2011, 3:682-696.
39. Robel S., et al. Genetic deletion of cdc42 reveals a crucial role for astrocyte recruitment to the injury site in vitro and in vivo. J. Neurosci. 2011, 31:12471-12482.
40. Rogatsky I., et al. Phosphorylation and inhibition of rat glucocorticoid receptor transcriptional activation by glycogen synthase kinase-3 (GSK-3). Species-specific differences between human and rat glucocorticoid receptor signaling as revealed through GSK-3 phosphorylation. J. Biol. Chem. 1998, 273:14315-14321.
41. Silver J., Miller J.H. Regeneration beyond the glial scar. Nat. Rev. Neurosci. 2004, 5:146-156.
42. Stambolic V., Woodgett J.R. Mitogen inactivation of glycogen synthase kinase-3 beta in intact cells via serine 9 phosphorylation. Biochem. J. 1994, 303(Pt 3):701-704.
43. Takayama S., et al. The glucocorticoid receptor represses cyclin D1 by targeting the Tcf-beta-catenin complex. J. Biol. Chem. 2006, 281:17856-17863.
44. Taniguchi Y., et al. Glucocorticoid receptor-beta and receptor-gamma exert dominant negative effect on gene repression but not on gene induction. Endocrinology 2010, 151:3204-3213.
45. Thylur R.P., et al. Mixed lineage kinase 3 modulates beta-catenin signaling in cancer cells. J. Biol. Chem. 2011, 286:37470-37482.
46. Wang X., et al. PRDM1 is directly targeted by miR-30a-5p and modulates the Wnt/beta-catenin pathway in a Dkk1-dependent manner during glioma growth. Cancer Lett. 2013, 331:211-219.
47. Wyszomierski S.L., et al. Glucocorticoid receptor/signal transducer and activator of transcription 5 (STAT5) interactions enhance STAT5 activation by prolonging STAT5 DNA binding and tyrosine phosphorylation. Mol. Endocrinol. 1999, 13:330-343.
48. Yan P., et al. Glucocorticoid receptor expression in the spinal cord after traumatic injury in adult rats. J. Neurosci. 1999, 19:9355-9363.
49. Yang H., et al. De-differentiation response of cultured astrocytes to injury induced by scratch or conditioned culture medium of scratch-insulted astrocytes. Cell. Mol. Neurobiol. 2009, 29:455-473.
50. Yang C., et al. beta-Catenin signaling initiates the activation of astrocytes and its dysregulation contributes to the pathogenesis of astrocytomas. Proc. Natl. Acad. Sci. U. S. A. 2012, 109:6963-6968.
51. Yoshioka S., et al. WNT7A regulates tumor growth and progression in ovarian cancer through the WNT/beta-catenin pathway. Mol. Cancer Res. 2012, 10:469-482.
52. Yuan X., et al. Isolation of cancer stem cells from adult glioblastoma multiforme. Oncogene 2004, 23:9392-9400.
53. Zeng G., et al. siRNA-mediated beta-catenin knockdown in human hepatoma cells results in decreased growth and survival. Neoplasia 2007, 9:951-959.
54. Zhang J., et al. High beta-catenin/Tcf-4 activity confers glioma progression via direct regulation of AKT2 gene expression. Neuro. Oncol. 2011, 13:600-609.
55. Zhang X., et al. Notch1 promotes glioma cell migration and invasion by stimulating beta-catenin and NF-kappaB signaling via AKT activation. Cancer Sci. 2012, 103:181-190.